+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07775404

Evaluating Elecogliprons Safety and Effectiveness for Weight Management in Asian Adults with Obesity or Overweight, With or Without Type 2 Diabetes

Led by AstraZeneca · Updated on 2026-10-01

351

Participants Needed

49

Research Sites

1 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and safety of elecoglipron compared with a placebo to help manage weight in adults living with obesity or overweight, including those with or without type 2 diabetes mellitus. This Phase III, randomized, double-blind, placebo-controlled study involves multiple centers and aims to assess elecogliprons impact on weight management over time. Participants will be randomly assigned to receive either one of two doses of elecoglipron or a matching placebo tablet taken once daily, alongside diet and exercise. The study will last for 52 weeks, during which efficacy and safety will be continuously evaluated. The study includes adults with a body mass index BMI of 28 kgm or higher, or those with a BMI between 24 and less than 28 kgm with at least one weight-related health issue. During the study, participants will undergo regular assessments including body weight measurements and waist circumference at baseline and at Week 52. Researchers will monitor changes in body weight, specifically the percent change from the start to Week 52, and the number of participants achieving at least 5% and 10% weight loss. Safety evaluations will be conducted throughout the trial to ensure participant well-being.

CONDITIONS

Brief Title

A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

Research Team

A

AstraZeneca Clinical Study Information Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here